pomalidomide (Pomalyst)

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Adverse effects

Mechanism of action

More general terms

References

  1. FDA News Release: Feb. 8, 2013 FDA approves Pomalyst for advanced multiple myeloma ww.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm338895.htm
  2. 2.0 2.1 Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022

Database